Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
A phase 2 study of alisertib (MLN8237) in recurrent or persistent uterine leiomyosarcoma: An NRG Oncology/Gynecologic Oncology Group study 0231D.
Journal: Gynecologic oncology
Published: August 17, 2016
Second Curettage for Low-Risk Nonmetastatic Gestational Trophoblastic Neoplasia.
Journal: Obstetrics and gynecology
Published: August 09, 2016
Attempted conservative management of a placental site trophoblastic tumor: a case report.
Journal: Connecticut medicine
Published: October 16, 2014
A phase II trial of brivanib in recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group Study.
Journal: Gynecologic oncology
Published: June 19, 2014
A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: a Gynecologic Oncology Group study.
Journal: Gynecologic oncology
Published: June 08, 2012
Showing 1-6 of 6
Last Updated: 09/26/2026